"10.1371_journal.pone.0010130","plos one","2010-04-12T00:00:00Z","Reyhan Nergiz-Unal; Judith M E M Cosemans; Marion A H Feijge; Paola E J van der Meijden; Robert F Storey; J J J van Giezen; Mirjam G A oude Egbrink; Johan W M Heemskerk; Marijke J E Kuijpers","Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands; Department of Cardiovascular Science, University of Sheffield, Sheffield, United Kingdom; AstraZeneca R&D Mölndal, Mölndal, Sweden; Department of Physiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands","Conceived and designed the experiments: JWMH MJEK. Performed the experiments: RNU JMEMC MAHF PEJvdM MJEK. Analyzed the data: RNU JMEMC MAHF PEJvdM MJEK. Contributed reagents/materials/analysis tools: RFS JJJvG MGAoE. Wrote the paper: JWMH MJEK.","J.J.J. van Giezen is an employee of AstraZeneca. Partial financial support for the conductance of this study was provided by AstraZeneca who own the patent for ticagrelor. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2010","04","Reyhan Nergiz-Unal","RNU",9,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
